NCT01455805

Brief Summary

Lumbar spinal stenosis (LSS), is a common disorder of narrowing of the spinal canal in the lower part of the back. This causes discomfort in the legs when standing or walking because of pressure on the spinal nerves.There are several treatment options for LSS including physiotherapy, lumbar surgical decompression procedures such as laminectomy, Foraminotomy, Discectomy and more recently devices for interspinous distraction such as the XSTOP® and from May 2011 Minuteman™. Surgical decompression for LSS involves the removal of excess bone, ligament, and soft-tissue allowing more room for the nerves. The operation is usually preformed under general anaesthetic and with an average stay in hospital for 2-3 nights. Whereas the Minuteman™ implant is preformed as a day case under local or general anaesthetic and involves implanting the device into the space between two back bones to relieve pressure on the nerves and, therefore, pain in the legs. This is a multi centred (four sites) randomised controlled trial with a total sample of 50 participants after obtaining their informed consent. Participants will attend the pain clinic at the Hospitals for a baseline visit where they will be randomised with a ratio of 1:1 to receive either the Minuteman™ Interspinous interlaminar fusion Implant or standard surgical decompression for the treatment of lumbar spinal stenosis (LSS). Following randomisation arrangements will be made for the participant to receive the randomised treatment. If allocated to Minuteman™ Implant, the treatment will be conducted by the Pain Specialist identified at the site. If allocated to surgical decompression, the treatment will be conducted by the neuro/spinal-surgeon identified at the site. Participates will be followed up regularly for 60 months post implant to assess clinical efficacy, safety, participants function and quality of life of each treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 13, 2011

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 20, 2011

Completed
8 months until next milestone

Study Start

First participant enrolled

June 1, 2012

Completed
11.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2024

Completed
Last Updated

April 11, 2024

Status Verified

April 1, 2024

Enrollment Period

11.8 years

First QC Date

October 13, 2011

Last Update Submit

April 10, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline of clinical efficacy up to 60 months post procedure

    These include: * Visual Analogue Scale (VAS) pain scores Leg Pain * Visual Analogue Scale (VAS) pain scores Back Pain * Oswestry Disability Index (ODI) * Zurich Claudication Questionnaire (ZCQ) * Assessment of Physical Function via distance walked in 5 minutes and number of repetitions of sitting to standing in 1 minute. The main outcome will be a comparison between treatment groups based on the change from baseline at each follow-up visit for each of the measures listed above.

    8 weeks and up to 60 months post procedure.

Secondary Outcomes (2)

  • measures of quality of life

    8 weeks and up to 60 months post procedure.

  • Adverse events related to device and procedure

    safety to be assessed at 8 weeks and up to 60 months post procedure.

Study Arms (2)

Minuteman Fusion Implant

ACTIVE COMPARATOR

Minuteman™ interspinous interlaminar fusion Implant (interspinous interlaminar fusion device) which gained CE Mark approval in May 2011

Device: Minuteman Fusion Implant

Surgical decompression

OTHER

Surgical decompression refers to the following operations Laminectomy, Foraminotomy, Discectomy or any other surgical procedure that the clinician feels is relevant for the decompression of lumbar spinal stenosis.

Procedure: surgical decompression

Interventions

The Minuteman™ interspinous interlaminar fusion device consists of a central threaded portion that has a two-part wing plate hinged near its proximal end, with spikes on the extended distal end of the wing plate, and a multi-spiked end cap plate that is located at the distal end of the device and is retained and tightened in place with a locking hex nut. Compression between the spiked wing plate and the spiked end cap plate serves to fix the spinous processes in place and to facilitate fusion, together with bone graft fusion material placed within the device. The threaded external body has been designed to provide ease of distraction and insertion via a minimally invasive surgical procedure.

Also known as: The Minuteman™ interspinous interlaminar fusion device
Minuteman Fusion Implant

Surgical decompression refers to the following operations Laminectomy, Foraminotomy, Discectomy or any other surgical procedure that the clinician feels is relevant for the decompression of lumbar spinal stenosis

Surgical decompression

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Is male or a non pregnant female aged 18years or older
  • BMI ≤ 35kg/m2
  • Has chronic leg pain with or without back pain of greater than 6 months duration,which is partially or completely relieved by either sitting or adopting a flexed posture and who are suitable in the clinicians opinion for posterior lumbar surgery
  • Pre-operative ODI score ≥ 20%
  • Pre-operative ZCQ Physical Function Domain ≥2
  • Pre-operative VAS Leg pain score ≥ 4
  • Has completed at least 6 months of conservative treatment without obtaining adequate symptomatic relief or has worsening neurological symptoms.
  • Has degenerative changes at 1 or 2 levels confirmed by MRI or CT Myelogram within the last 12 months) with one or more of the following:
  • Lumbar spinal stenosis with intermittent neurogenic claudication
  • Degeneration of the disc (as evidenced by imaging on MRI)
  • Annular thickening
  • Degenerative Spondylolisthesis ≤ Meyerding Grade 1
  • Thickening of ligamentum flavum

You may not qualify if:

  • Fixed motor deficit
  • Has undergone previous lumbar spinal surgery
  • Is unwilling or unable to give consent or adhere to the follow up schedule
  • Has active infection or metastatic disease
  • Has spondylolisthesis \> grade 1
  • Has neurogenic bladder or bowel disease
  • Has a history of Osteopenia and or Osteoporosis. Evaluation of possible Osteopenia and or Osteoporosis will be conducted via a bone density scan prior to randomisation if ANY of the Bone Mass Evaluation criteria is met
  • Patients who are not deemed fit for anaesthesia/major surgery due to underlying medical condition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Taunton & Somerset NHS Foundation Trust of Musgrove Park Hospital

Taunton, Somerset, TA1 5DA, United Kingdom

Location

The Ipswich Hospital NHS Trust

Ipswich, Suffolk, IP4 5PD, United Kingdom

Location

Pain and Interventional Neuromodulation Research Group, Pain Management Dept, Seacroft Hospital, Leeds Teaching Hospitals NHS Trust

Leeds, West Yorkshire, LS14 6UH, United Kingdom

Location

The Dudley Group NHS Foundation Trust, Russell Hall Hospital

Birmingham, DY1 2HQ, United Kingdom

Location

MeSH Terms

Conditions

Spinal StenosisSpondylolisthesisIntervertebral Disc Degeneration

Interventions

Decompression, Surgical

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal DiseasesSpondylolysisSpondylosis

Intervention Hierarchy (Ancestors)

Surgical Procedures, Operative

Study Officials

  • Ganesan Baranidharan, Dr

    Leeds Teaching Hospitals NHS Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 13, 2011

First Posted

October 20, 2011

Study Start

June 1, 2012

Primary Completion

March 1, 2024

Study Completion

March 1, 2024

Last Updated

April 11, 2024

Record last verified: 2024-04

Locations